Develops immunotherapy for bladder cancer.
Jun 2026Revenue $6.23M/yrExpenses $259M/yr
No trendCash runway ≈ 5.7 years from Jun 2026
Figures by year
When will CG Oncology be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $6.23M and expenses $259M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $4.04M | $195M | −$191M |
| Dec 2024 | $1.14M | $116M | −$115M |
| Dec 2023 | $204K | $55.7M | −$55.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.